Literature DB >> 28098934

Clinical, ultrasound parameters and tumor marker-based mathematical models and scoring systems in pre-surgical diagnosis of adnexal tumors.

Nabil Abdalla1, Joanna Winiarek, Michał Bachanek, Krzysztof Cendrowski, Włodzimierz Sawicki.   

Abstract

The choice of management for patients with adnexal tumors requires careful pre-surgical assessment. In case of adnexal masses, the diagnostic difficulties arise from the heterogenic nature of the adnexal diseases, presence of multiple functional changes, and lack of early symptoms of malignancy. A reliable pre-surgical differentiation cannot be performed using clinical features, ultrasound examination, or tumor markers alone. New diagnostic techniques and novel markers are under investigations, however no single test can be used to conclusively differentiate between malignant and non-malignant adnexal masses. Mathematical models and scoring systems based on different clinical, ultrasonographic and laboratory parameters alone or together may facilitate the diagnosis. Selected mathematical models and scoring systems are presented in this article. Models using only ultrasound features include simple rules, regression models, Gynecologic Imaging Report and Data System, and various morphologic scores. Some logistic regression models are based on multiple clinical and ultrasound data. The OVA1 test is based on five tumor markers without using other data. The Risk of Malignancy Algorithm uses two tumor markers with one clinical parameter. i.e. the menopausal status. Some models used clinical, ultrasound and tumor marker data together. This group of models includes risk of malignancy indices, artificial neural networks, and the ADNEX model. Although some of these models have been compared in the literature, more prospective studies are needed to select the most effective model, to develop the existing models, or to create new more effective models of oncological assessment of the adnexal tumors.

Entities:  

Keywords:  biomarkers; ovarian neoplasms; risk assessment; ultrasonography

Mesh:

Substances:

Year:  2016        PMID: 28098934     DOI: 10.5603/GP.2016.0096

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  4 in total

1.  Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1-4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

Authors:  Nabil Abdalla; Robert Piórkowski; Paweł Stanirowski; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

2.  Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?

Authors:  Nabil Abdalla; Robert Piorkowski; Michal Bachanek; Pawel Stanirowski; Krzysztof Cendrowski; Wlodzimierz Sawicki
Journal:  Dis Markers       Date:  2018-04-10       Impact factor: 3.434

3.  Presurgical diagnostic difficulties in an asymptomatic patient with primary transitional cell carcinoma of the oviduct: case report.

Authors:  Nabil Abdalla; Anna Wnuk; Seweryn Trojanowski; Alicja Jakimiuk; Pawel Stanirowski; Krzysztof Cendrowski; Wlodzimierz Sawicki
Journal:  Prz Menopauzalny       Date:  2018-06-30

4.  Detection of Epithelial Ovarian Cancer using C8Magnetic Bead Separation and MALDI-TOF Plasma Proteome Profiling in Egyptian Females.

Authors:  Mohamed Mostafa Rizk; Ola Atef Sharaki; Mahmoud Elsayed Meleis; Doreen Nazeih Younan; Alyaa Abdallah Elkial; Pacinte Moez
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.